by United Pompe | Jan 18, 2016 | News
Genzyme Files for European Approval of Myozyme For Treatment of Pompe Disease Date: December 20, 2004 Genzyme Corp. (Nasdaq: GENZ) announced today that the European Medicines Agency (EMEA) has accepted its marketing authorization application for Myozyme...
by United Pompe | Jan 18, 2016 | News
Genzyme Pompe Program Update May 2004 Genzyme’s Pompe Program has progressed on many fronts over the last 6 months, and we are optimistic that the development of rhGAA will continue to proceed rapidly and responsibly. Infantile Onset Genzyme has two...
by United Pompe | Jan 18, 2016 | News
IPA /Genzyme Joint Pompe Program Update, August 2004 Infantile-Onset Expanded Access Program Enrollment in the Infantile Expanded Access Program is currently on-going. Physicians who may have an infantile-onset Pompe patient should contact Genzyme Medical...
by United Pompe | Jan 18, 2016 | News
IPA Summary of Genzyme Press Release The Genzyme press release about the Pompe program put on GSD net by our IPA board member Allan Muir a week ago will probably raise some questions. With a summary description IPA would like to answer them. Genzyme informed us about...
by United Pompe | Jan 18, 2016 | News
Letter From Jan van Heek On Saturday, March 9th, 2002, I will be speaking at the VSN (The Dutch Muscular Dystrophy Association, Vereniging Spierziekten Nederland) Annual Patient Conference in The Netherlands. At the conference I will provide a general overview of...
